![]() Catalyst Pharmaceuticals Catalyst Pharmaceuticals is a biopharmaceutical company focused on developing and commercializing innovative therapies for people with rare debilitating diseases. | ![]() Merus Merus is a clinical-stage immuno-oncology company developing innovative bispecific antibody therapeutics with the goal of treating and potentially curing cancer patients. | |
Founding Date | Founding Date 2002 | Founding Date 2003 |
Type | Type Public | Type Public |
Tags | ||
Locations | Locations Coral Gables, US HQ | Locations Utrecht, NL HQ Cambridge, US |
Employees | Employees 7649% increase | Employees 260 |
Valuation ($) | Valuation ($) 2.6 b | Valuation ($) 3.6 b |
Financial | ||
Revenue (est.) | Revenue (est.) $589m (FY, 2025) | Revenue (est.) $36.1m (FY, 2024) |
Cost of goods | Cost of goods $87.3m (FY, 2025) | Cost of goods N/A |
Gross profit | Gross profit $501.7m (FY, 2025) | Gross profit $36.1m (FY, 2024) |
Net income | Net income $214.3m (FY, 2025) | Net income ($215.3m) (FY, 2024) |

Merus is a clinical-stage immuno-oncology company developing innovative bispecific antibody therapeutics with the goal of treating and potentially curing cancer patients.
View company